- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.05. | FDA weighs drug repurposing pathway for underserved diseases | ||
| 12.05. | BridgeBio's Attruby challenges Pfizer's Vyndamax legacy in pivotal ATTR trial | ||
| 12.05. | GSK and SBP Group team up to advance bepirovirsen launch in China | ||
| 12.05. | Partner Therapeutics secures FDA approval for Bizengri | ||
| 11.05. | Cellular Intelligence licenses Novo's shelved Parkinson's cell therapy programme | ||
| 11.05. | FDA locks down post-approval pregnancy safety data framework | ||
| 11.05. | ACROBiosystems upgrades HEK293 licence solution for R&D compliance | ||
| 11.05. | BMS' Sotyktu secures EC approval for psoriatic arthritis | ||
| 08.05. | Gilead posts positive Q1 buoyed by HIV drug growth | ||
| 08.05. | Novo's CEO champions "record-breaking start" for Wegovy pill in US market | ||
| 08.05. | Construction begins on Novartis' RLT centre in Texas, US | ||
| 08.05. | Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn | ||
| 07.05. | GSK spends $1bn on rights to SiranBio's metabolic oligonucleotide | ||
| 07.05. | Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing | ||
| 07.05. | Daiichi Sankyo and Waiv partner for ADC biomarkers | ||
| 07.05. | Halozyme and Oruka sign agreement for Hypercon technology | ||
| 06.05. | Bayer looks to uphold Eylea legacy with $2.45bn Perfuse buyout | ||
| 06.05. | Citius raises $36.5m for Lymphir commercialisation | ||
| 06.05. | DDW 2026: key readouts from the conference | ||
| 06.05. | Arrowhead and Madrigal sign global licence for MASH RNAi therapy | ||
| 06.05. | MSD concludes Terns acquisition to expand CML pipeline | ||
| 05.05. | Madrigal outlays $1bn for Arrowhead's siRNA MASH asset | ||
| 05.05. | UCB doubles down on TCEs with $2.2bn Candid buyout | ||
| 05.05. | Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara | ||
| 05.05. | Latus Bio secures $97m in funding to boost gene therapy access |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.